In the Union Budget 2026–27, Finance Minister Nirmala Sitharaman highlighted the shifting health challenges facing India and announced a major initiative to strengthen the country’s biopharmaceutical ecosystem. Central to her announcement was the launch of the “Biopharma Shakti” programme, backed by an allocation of ₹10,000 crore over the next five years to boost domestic capability in advanced drug manufacturing and healthcare innovation.










